Literature DB >> 23339288

Review: microglia in protein aggregation disorders: friend or foe?

S M Gentleman1.   

Abstract

Microglia cells have been implicated, to some extent, in the pathogenesis of all of the common neurodegenerative disorders involving protein aggregation such as Alzheimer's disease, Parkinson's disease and Amyotrophic Lateral Sclerosis. However, the precise role they play in the development of the pathologies remains unclear and it seems that they contribute to the pathological process in different ways depending on the specific disorder. A better understanding of their varied roles is essential if they are to be the target for novel therapeutic strategies.
© 2013 British Neuropathological Society.

Entities:  

Mesh:

Year:  2013        PMID: 23339288      PMCID: PMC3580295          DOI: 10.1111/nan.12017

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  51 in total

1.  Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

Authors:  Bing Liao; Weihua Zhao; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Exp Neurol       Date:  2012-06-23       Impact factor: 5.330

Review 2.  Microglial senescence: does the brain's immune system have an expiration date?

Authors:  Wolfgang J Streit
Journal:  Trends Neurosci       Date:  2006-07-20       Impact factor: 13.837

Review 3.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain.

Authors:  Uwe-Karsten Hanisch; Helmut Kettenmann
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

4.  Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Lih Fen Lue; Donald J Connor; John N Caviness; Marwan N Sabbagh; Charles H Adler
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

5.  Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease.

Authors:  L G Sheffield; J G Marquis; N E Berman
Journal:  Neurosci Lett       Date:  2000-05-19       Impact factor: 3.046

6.  Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.

Authors:  Kazuyuki Takata; Yoshihisa Kitamura; Daijiro Yanagisawa; Shigehiro Morikawa; Masahito Morita; Toshiro Inubushi; Daiju Tsuchiya; Saori Chishiro; Mana Saeki; Takashi Taniguchi; Shun Shimohama; Ikuo Tooyama
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

7.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.

Authors:  Joseph El Khoury; Michelle Toft; Suzanne E Hickman; Terry K Means; Kinya Terada; Changiz Geula; Andrew D Luster
Journal:  Nat Med       Date:  2007-03-11       Impact factor: 53.440

8.  Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  Neuropathol Appl Neurobiol       Date:  1995-08       Impact factor: 8.090

9.  The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells.

Authors:  Coral-Ann Lewis; John Manning; Fabio Rossi; Charles Krieger
Journal:  Neurol Res Int       Date:  2012-05-15

10.  Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

Authors:  Carol A Colton; Ryan T Mott; Hayley Sharpe; Qing Xu; William E Van Nostrand; Michael P Vitek
Journal:  J Neuroinflammation       Date:  2006-09-27       Impact factor: 8.322

View more
  9 in total

1.  CSF1 overexpression has pleiotropic effects on microglia in vivo.

Authors:  Ishani De; Maria Nikodemova; Megan D Steffen; Emily Sokn; Vilena I Maklakova; Jyoti J Watters; Lara S Collier
Journal:  Glia       Date:  2014-07-05       Impact factor: 7.452

Review 2.  Sumoylation of critical proteins in amyotrophic lateral sclerosis: emerging pathways of pathogenesis.

Authors:  Emily Foran; Lauren Rosenblum; Alexey I Bogush; Davide Trotti
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

3.  Origin of fundus hyperautofluorescent spots and their role in retinal degeneration in a mouse model of Goldmann-Favre syndrome.

Authors:  Nan-Kai Wang; Chi-Chun Lai; Chi-Hsiu Liu; Lung-Kun Yeh; Chai Lin Chou; Jian Kong; Takayuki Nagasaki; Stephen H Tsang; Chung-Liang Chien
Journal:  Dis Model Mech       Date:  2013-07-04       Impact factor: 5.758

4.  The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.

Authors:  Faris Yaghmoor; Ahmed Noorsaeed; Samar Alsaggaf; Waleed Aljohani; Henrieta Scholtzova; Allal Boutajangout; Thomas Wisniewski
Journal:  J Alzheimers Dis Parkinsonism       Date:  2014-11

5.  SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2.

Authors:  Patricia Richard; James L Manley
Journal:  Rare Dis       Date:  2014-01-21

6.  Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.

Authors:  Gregory Scott; Henrik Zetterberg; Amy Jolly; James H Cole; Sara De Simoni; Peter O Jenkins; Claire Feeney; David R Owen; Anne Lingford-Hughes; Oliver Howes; Maneesh C Patel; Anthony P Goldstone; Roger N Gunn; Kaj Blennow; Paul M Matthews; David J Sharp
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

7.  Traumatic brain injury-related inflammatory projection: beyond local inflammatory responses.

Authors:  Sanae Hosomi; Mitsuo Ohnishi; Hiroshi Ogura; Takeshi Shimazu
Journal:  Acute Med Surg       Date:  2020-06-04

Review 8.  Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.

Authors:  Md Ezazul Haque; In-Su Kim; Md Jakaria; Mahbuba Akther; Dong-Kug Choi
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

Review 9.  Network dysfunction after traumatic brain injury.

Authors:  David J Sharp; Gregory Scott; Robert Leech
Journal:  Nat Rev Neurol       Date:  2014-02-11       Impact factor: 42.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.